ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 980 filers reported holding ASTRAZENECA PLC in Q1 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,420,334 | -93.5% | 120,789 | -94.4% | 0.00% | -96.0% |
| Q4 2023 | $143,999,015 | -43.6% | 2,138,070 | -40.0% | 0.02% | -50.0% |
| Q2 2023 | $255,144,044 | -2.8% | 3,564,958 | -5.7% | 0.05% | -12.3% |
| Q1 2023 | $262,360,707 | +3.2% | 3,779,869 | +0.8% | 0.06% | -6.6% |
| Q4 2022 | $254,290,205 | +19.5% | 3,750,593 | -3.3% | 0.06% | +7.0% |
| Q3 2022 | $212,709,718 | -61.1% | 3,878,733 | -53.1% | 0.06% | -59.6% |
| Q2 2022 | $546,459,024 | -9.5% | 8,270,910 | -9.1% | 0.14% | +6.8% |
| Q1 2022 | $603,876,899 | +11.4% | 9,102,757 | -2.2% | 0.13% | +18.9% |
| Q4 2021 | $542,230,000 | -3.7% | 9,308,677 | -0.7% | 0.11% | -11.2% |
| Q3 2021 | $563,283,000 | +31904.7% | 9,378,677 | +31820.9% | 0.12% | – |
| Q2 2021 | $1,760,000 | +20.5% | 29,381 | 0.0% | 0.00% | – |
| Q1 2021 | $1,461,000 | -0.5% | 29,381 | 0.0% | 0.00% | – |
| Q4 2020 | $1,469,000 | -8.8% | 29,381 | 0.0% | 0.00% | – |
| Q3 2020 | $1,610,000 | -88.5% | 29,381 | -88.9% | 0.00% | -100.0% |
| Q2 2020 | $13,948,000 | +10.3% | 263,725 | -6.9% | 0.00% | -20.0% |
| Q1 2020 | $12,646,000 | +247.9% | 283,153 | +288.3% | 0.01% | +400.0% |
| Q4 2019 | $3,635,000 | -64.8% | 72,912 | -73.2% | 0.00% | -75.0% |
| Q4 2018 | $10,337,000 | -35.2% | 272,167 | -32.5% | 0.00% | -20.0% |
| Q3 2018 | $15,952,000 | +51.1% | 403,125 | +34.0% | 0.01% | +25.0% |
| Q2 2018 | $10,560,000 | +0.4% | 300,771 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $10,518,000 | +0.8% | 300,771 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $10,437,000 | +2.4% | 300,771 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $10,190,000 | -0.6% | 300,771 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $10,253,000 | +9.5% | 300,771 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $9,366,000 | +14.0% | 300,771 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $8,217,000 | -13.0% | 300,771 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $9,440,000 | +4.0% | 300,771 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $9,080,000 | +7.2% | 300,771 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $8,470,000 | -17.1% | 300,771 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $10,211,000 | +6.7% | 300,771 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $9,571,000 | -78.5% | 300,771 | -56.9% | 0.01% | -77.3% |
| Q2 2015 | $44,427,000 | -6.9% | 697,329 | 0.0% | 0.02% | -4.3% |
| Q1 2015 | $47,718,000 | -2.8% | 697,329 | 0.0% | 0.02% | -8.0% |
| Q4 2014 | $49,078,000 | -1.5% | 697,329 | 0.0% | 0.02% | -7.4% |
| Q3 2014 | $49,817,000 | -51.9% | 697,329 | -50.0% | 0.03% | -3.6% |
| Q2 2014 | $103,638,000 | +129.1% | 1,394,658 | +100.0% | 0.03% | +7.7% |
| Q1 2014 | $45,243,000 | +9.3% | 697,329 | 0.0% | 0.03% | +8.3% |
| Q4 2013 | $41,400,000 | +14.3% | 697,329 | 0.0% | 0.02% | +14.3% |
| Q3 2013 | $36,212,000 | +9.8% | 697,329 | 0.0% | 0.02% | +5.0% |
| Q2 2013 | $32,984,000 | -5.4% | 697,329 | 0.0% | 0.02% | -13.0% |
| Q1 2013 | $34,853,000 | +4.4% | 697,329 | 0.0% | 0.02% | +4.5% |
| Q3 2012 | $33,374,000 | +2.2% | 697,329 | 0.0% | 0.02% | -15.4% |
| Q2 2012 | $32,642,000 | – | 697,329 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |